Carletti P, Bibiano L, Boggi R, Bordoni E, Ricciatti A M, Della Bella S, Pauri P, Salvoni G, Mioli V A
Divisione di Nefrologia e Dialisi, Ospedale Regionale, Torrette, Ancona, Italy.
Nephron. 1992;61(3):269-70. doi: 10.1159/000186901.
From 1986 to 91, 174 dialysis patients were studied. The prevalence of previous HBV infection and of chronic carriers was 33.3 and 4.6%, respectively. Immunization rate after vaccination (3 doses) was 63%. In 1991, we proposed a vaccination with 4 doses and recommend a 6-monthly anti-HBs evaluation to assess the timing of any booster dose needed.
1986年至1991年，对174名透析患者进行了研究。既往乙肝病毒（HBV）感染率和慢性携带者患病率分别为33.3%和4.6%。接种疫苗（3剂）后的免疫率为63%。1991年，我们提议接种4剂疫苗，并建议每6个月进行一次乙肝表面抗体（抗-HBs）评估，以确定所需加强剂量的接种时间。
